U.S. HIV/Aids program blending food aid (26/04/07)

 

The United States is combining nutritional assistance with anti-retroviral drug therapy to boost the effectiveness of HIV/AIDS prevention and treatment programs in developing countries, says Michele Maloney-Kitts, program director of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR).

 
 
A "complex interface exists between the prevalence of HIV infection and chronic food insecurity," Maloney-Kitts said April 17 at the International Food Aid Conference in Kansas City, Missouri. Because AIDS is "a wasting disease," people with it have "increasing energy needs," she said.

Established in 2004, PEPFAR is a five-year, $15 billion commitment with a particular focus on the 15 countries that are among the world's most severely affected by HIV/AIDS.

Also working in 100 other countries, PEPFAR is the largest public health initiative dedicated to a single disease undertaken by any nation.

PEPFAR partners with the U.S. Agency for International Development and the U.S. Department of Agriculture, which administer U.S. food aid programs, to provide food to groups in the targeted countries that are vulnerable to malnutrition, including children born to women infected with HIV, pregnant women, lactating mothers and children orphaned by AIDS, she said.

Children who are HIV-positive at birth are more likely to need enhanced nutrition because they often begin life underweight. Without proper nutrition, these children are more likely to have stunted growth and be susceptible to other infections, according to PEPFAR officials.

The agency also partners with the U.N. World Food Programme (WFP), which receives nearly half its resources from the United States, host country governments, foundations and nongovernmental organizations to help sick and vulnerable people receive life-saving nutrients.

One such partnership is with the Academic Model for the Prevention and Treatment of HIV (AMPATH), an initiative that emphasizes food and economic security in addition to anti-retroviral drugs for people affected by HIV in Kenya, said Maloney-Kitts.

Source: USINFO

To receive regular email alerts, contact us at updates@developmentprogram.org

Click here for Newsletter Archive

   
 
Home Concept The Issues HDP Events Sustainable Development Stats Info Centre
    Resources BFAFA Support Contact    
  © Copyright Development Program 2007